The EMCL-Registry
Building knowledge together
Mantle cell lymphoma (MCL) is a rare cancer of the lymphatic system. Although treatment options have improved significantly in recent years, many questions remain that cannot be answered in clinical trials alone. To answer these questions, the EMCL Registry was established by the European MCL Network.
Registry data can help to evaluate open questions by collecting real world information about treatments and disease courses. Routine data only is collected – no additional examinations are required. More than 2,500 patients are already participating.
The EMCL Registry is part of the European MCL Network and is coordinated by the University Medical Center Mainz.